MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Gold and silver nanoparticle-based Localized Surface Plasmon Resonance Sensor (LSPR) for the detection of histidine as a potential biomarker in Parkinson’s Disease.

E. Robles, C. Acevedo-Castillo, D. Martínez-Ramírez (Monterrey, Mexico)

Meeting: 2022 International Congress

Abstract Number: 391

Keywords: Dopaminergics, Parkinson’s, Striatonigral degeneration

Category: Technology

Objective: Previous literature has proven that histamine has a crucial role in the process of neuroinflammation in Parkinson’s Disease (PD) . We can indirectly detect histamine levels in fluid samples by quantifying levels of histidine. Therefore, we developed a gold and silver nanoparticle-based LSPR sensor for the detection of histidine. 

Background: The central histaminergic system is one of the subcortical  aminergic  projection  systems  involved  in several  regulatory  functions. It is known that the  central  dopaminergic and  histaminergic  systems  interact in diseases affecting the dopaminergic neurons, one of them being PD. Sensitive determination of specific biomarkers could help the medical community to provide better early diagnosis and disease modifying therapies for patients with Parkinson’s Disease.

Method: Au/Ag and Au, Ag nanoparticles were synthesized. Histidine was prepared at different concentrations: 10 mM, 25mM, and 100 mM. UV-Vis spectroscopy was used to determine the absorbance spectrums of the nanoparticles with histidine. Additionally, a spearman analysis was done for the absorbance values measured from 190 nm to 360 nm in all three concentrations in order to evaluate the significance of the study and to observe correlations between the variables.

Results: In all concentrations a higher absorbance was obtained with the metallic systems. At 10 mM both Au and Ag generated a better signal than histidine alone, at a wavelength of 217 nm with an absorbance of 0.76 at 25 mM, Au emitted the highest signal at a wavelength of 221 with an absorbance of 0.39 and at 100 mM the system Au/Ag generated a better signal at a wavelength of 209.0 at an absorbance of 0.89. Additionally, the conducted spearman analysis indicated p < 0.001 in all concentrations.

Conclusion: We successfully developed an LSPR sensor that improved the detection of histidine. Our findings could help to easily identify abnormal levels of relevant biomarkers in PD and contribute to early detection of this disease.

Grafica

References: references

To cite this abstract in AMA style:

E. Robles, C. Acevedo-Castillo, D. Martínez-Ramírez. Gold and silver nanoparticle-based Localized Surface Plasmon Resonance Sensor (LSPR) for the detection of histidine as a potential biomarker in Parkinson’s Disease. [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/gold-and-silver-nanoparticle-based-localized-surface-plasmon-resonance-sensor-lspr-for-the-detection-of-histidine-as-a-potential-biomarker-in-parkinsons-disease/. Accessed May 25, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/gold-and-silver-nanoparticle-based-localized-surface-plasmon-resonance-sensor-lspr-for-the-detection-of-histidine-as-a-potential-biomarker-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley